Introduction
New growth factor (NGF) and the related neurotrophins (brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3)), affect the biological behavior of neuronal cells during the development, survival and differentiation of the central and peripheral nervous systems. The biological effects of the neurotrophins are also detected in the progression and development of glial tumors and neuronal tumors such as medulloblastomas and neuroblastomas (NBs).
NB is a malignant childhood tumor of neural crest origin, which can arise anywhere along the sympathetic ganglia chain or within the adrenal medulla. While some tumors may spontaneously stop proliferating and regress, others continue to proliferate and can metastasize to the CNS. Neurotrophins and their tyrosine kinase receptors (TrkA, TrkB and TrkC) play an important role in the biology and clinical outcome of NBs. Observations from several studies indicate, first of all, that expression of TrkA and TrkC correlate with good prognosis of the disease (Kogner et al., 1993; Nakagawara et al., 1993; Ryden et al., 1996; Yamashiro et al., 1996) . Secondly, correlations between prognostic markers and the progression of tumor development have been established. Specifically, N-myc amplification is associated with poor prognosis (Brodeur et al., 1984; Seeger et al., 1985) and, most importantly, the examination of TrkA expression and N-myc amplification has shown that TrkA expression is associated with an absence of N-myc amplification, lower disease stage, lower patient age and a favorable outcome (Nakagawara et al., 1992) . Finally, tumors expressing full-length TrkB and BDNF are usually associated with poor prognosis and N-myc amplification (Nakagawara et al., 1994) . Collectively, these findings suggest that differential activation of the Trks in NBs may have different functional consequences on the progression of this type of tumor.
While the molecular mechanisms controlling the spontaneous regression of NBs are unknown, there is plenty of evidence from in vitro work demonstrating that NGF-dependent differentiation occurs when NBs are transfected with a wild-type TrkA cDNA (Matsushima and Bogenmann, 1993; Poluha et al., 1995) . In an effort to identify which intracellular pathways underscore the differentiative response in NBs, the NGF-dependent signalling mechanisms have been investigated in lines expressing wild-type TrkA in comparison to lines expressing a series of different Trk receptor mutants (Eggert et al., 2000) .
In ) are essential to receptor phosphorylation/activation and directly bind the adapter proteins Grb2 (MacDonald et al., 2000) , SH2B and rAPS (Qian et al., 1998) , while Tyr 499 and Tyr 794 are required for receptor binding and tyrosine phosphorylation of Shc/FRS2 and PLCg-1/CHK, respectively (Obermeier et al., 1994; Stephens et al., 1994; Meakin et al., 1999; Yamashita et al., 1999) . Studies in Trk-expressing NBs indicate that Shc, PLCg-1, FRS2 and MAP kinase are also activated in response to NGF, although it has been suggested that there may be slight differences in the underlying signalling pathways regulating differentiation in NBs as compared to PC12 cells. Specifically, using TrkA mutants that cannot directly recruit and/or activate Shc, FRS2 and PLCg-1, NGF-dependent differentiation is retained in NBs, albeit at a reduced level, as compared to wild-type TrkA (Eggert et al., 2000) . Since this same receptor mutant effectively blocks differentiation in PC12 cells (Stephens et al, 1994) , it has raised the model that there may be differences in the cellular components essential to differentiation in the two cell types. In particular, it has been reported that the signalling adapter protein SH2B (Qian et al., 1998) is tyrosine phosphorylated in NGF-stimulated TrkA-expressing NB cells, but not in NGF-stimulated PC12 cells (Eggert et al., 2000) . Interestingly, SH2B is thought to be directly recruited and/or activated via the activation loop tyrosines themselves (Tyr 683 , Tyr
684
; Qian et al., 1998) , and overexpression of SH2B can reconstitute NGF-dependent differentiation in nnr5 cells cotransfected with a mutant TrkA in which all Tyr residues, except the activation loop tyrosines, are substituted with phenylalanine (F8) (Qian et al., 1998) . These observations have led to a model that SH2B, via the activation loop tyrosines, can support an alternate route of Grb2/Sos/ Ras/MAPK activation resulting in differentiation. Moreover, these observations suggest that mechanisms supporting differentiation in NBs may be different, as a result of SH2B expression, as compared to PC12 cell-derived nnr5 cells. Even though several redundant pathways are activated in NB and PC12 cells, the consistent signalling pathway supporting NGFmediated differentiation is the prolonged activation of MAP kinase.
As the NGF-induced differentiation of TrkA-transfected NBs is dependent on TrkA kinase activity, and it has been suggested that SH2B activation, via the activation loop tyrosines, might be an important pathway supporting differentiation in NBs, we determined if the acidic amino-acid substitution mutants in the activation loop tyrosines, AspGlu and GluAsp, could mediate NGF-independent kinase activation and differentiation of transfected NB cells, as we previously observed in stably transfected nnr5 cells . Specifically, the GluAsp and AspGlu mutant Trks were assayed and scored with respect to their intrinsic kinase activity, the phosphorylation and/ or activation of signalling molecules, as well as their ability to induce differentiation in the human NB cell line, SY5Y. SY5Y is a subclone of the SK-N-SH cell line, which was established from a bone marrow aspirate of a human, thoracic NB (Biedler et al., 1973) . SY5Y cells express very low levels of TrkA, and do not respond to NGF by differentiation and/or survival in serum-free medium (Lavenius et al., 1995) . However, these responses can be reconstituted by transfection with the wild-type TrkA cDNA (Poluha et al., 1995; Eggert et al., 2000) .
In this study, the AspGlu and GluAsp mutant Trks have been conditionally expressed, using a tetracyclineinducible system, and analysed for their ability to support NGF-independent and NGF-dependent neuritogenesis and cell signalling. Interestingly, contrary to our previous observations in PC12-derived nnr5 cells, we find that the AspGlu and GluAsp mutant Trks cannot support NGF-independent autophosphorylation or neuritogenic responses in SY5Y cells. Rather, the AspGlu and GluAsp mutant Trks support NGFdependent neurite outgrowth to levels that are approximately 30-60 and 50-60%, respectively, of wild-type Trk. Moreover, the compromised ability of the AspGlu mutant Trk, in comparison to GluAsp, to induce NGFdependent neuritogenesis cannot be explained by absolute differences in the activation profiles of individual cell signalling markers such as Shc, PLCg-1, MAP kinase, FRS2 or SH2B; rather, we find that the AspGlu mutant receptor does not effectively arrest cell cycle progression.
Results

SY5Ycells expressing wild-type and mutant Trks, AspGlu and GluAsp
Previously, we have shown that AspGlu and GluAsp substitution of the activation loop tyrosines on TrkA stimulates constitutive, self-activation in nnr5 cells ; thus, these mutants have been further assayed for constitutive activation/differentiation in the human NB cell line, SY5Y. An inducible tetracycline (tet) system was used to regulate TrkA expression, since constitutive expression could possibly induce cell cycle arrest and neurite outgrowth. HAtagged wild-type TrkA and the AspGlu/GluAsp mutants were subcloned into the autoregulated, bidirectional expression vector, pBig3i (Strathdee et al., 1999) . In this format, the transactivator (rTA) and the rTAregulated gene are encoded on the same vector, simplifying the expression of genes in mammalian cells. Stable expression of wild-type and mutant Trks in SY5Y cells was carried out by hygromycin selection and isolated clones were scored for TrkA expression in the presence of doxycycline (Dox; 2.0 mg/ml, 24 h). Three independent lines expressing wild-type and mutant Trks were selected (see Table 1 ).
To determine if the selected clones represent a homogenous population of cells, fluorescence-activated cell sorting (FACS) analysis was performed using anti-HA antibodies against the N-terminal tag on the Trks. To determine the percentage of cells that express surface receptors, half of the cells were stained only with the FITC-coupled secondary antibodies to account for nonspecific binding and fluorescence. Importantly, all selected clones appear relatively homogeneous, but express only low levels of cell-surface receptors, as the increase in fluorescence intensity is only weakly above background. Specifically, the proportion of cells expressing TrkA to levels that are above background has been consistently found (in three independent assays) to be approximately 10% for Trk19, 6% for Trk20, 8% for 13a6 (AspGlu), 10% for 13a8 (AspGlu), 6% for 13b2 (GluAsp) and 9% for 13b24 (GluAsp) (data not shown).
In an effort to increase the percentage of cells expressing TrkA, cells were sorted three times. Unfortunately, we were unable to enhance the level of receptors in the selected clones, suggesting that the clones express a relatively homogenous, yet low, number of Trk receptors per cell.
NGF-independent phosphorylation of TrkA mutant receptors
Our initial experiments indicated that the AspGlu and GluAsp mutant Trks in SY5Y cells could not become activated in the absence of NGF stimulation (see below); thus, we determined if this was attributable to low levels of receptor expression. To this end, we generated recombinant adenoviruses expressing AspGlu and GluAsp to infect SY5Y cells. To determine the relative level of Ad-infected receptor expression obtained in comparison with our stable lines, we induced the stable SY5Y cell lines to express both the wild-type and mutant Trks, and analysed the lysates concurrently with those obtained from adenoviral infection. To assay constitutive activity, cultures were assayed for NGFindependent and NGF-induced TrkA phosphorylation. Lysates from Dox-induced (2.0 mg/ml, 24 h), adenovirusinfected cells (multiplicity of infection of 10 : 1, 24 h), unstimulated or NGF stimulated, were immunoprecipitated with anti-trk antibodies and assayed by Western blotting with both anti-pTyr and anti-HA antibodies. Blots were analysed by densitometry to assay levels of receptor phosphorylation and expression in relation to a previously characterized nnr5 cell line expressing wildtype TrkA, B5 (expressing approximately 80-90-fold more receptors per cell than PC12 cells; Meakin and MacDonald, 1998) , as well as in comparison to our previously described nnr5 cell lines expressing S13a and S13b . As shown in Figure 1a and b, the AspGlu and GluAsp mutant Trks, in SY5Y cells, do not support NGF-independent autophosphorylation (a: lanes 7, 9 and b: lanes 6, 8 and 10). Figure 1c) . By comparison, however, GluAsp and AspGlu mutant receptor expression in SY5Y clones is consistently lower than that obtained in nnr5 cells (Figure 1d ; Gryz and Meakin, 2000) , suggesting that the lack of constitutive activation may reflect a lower density of receptor expression per cell. Consistent with this interpretation, high overexpression of AspGlu and GluAsp in SY5Y cells, following infection with adenoviruses (approximately 250-fold; see Figure 1c ), does induce NGF-independent autophosphorylation ( Figure 1a, lanes 12 and 14) . Similar results were found in three independent experiments.
Biological responsiveness
The ability of the AspGlu and GluAsp mutants to support neurite outgrowth was assessed in two or three lines induced to express each construct. To ensure that quantification of the response was representative, the neurite response assay was performed under both high (10%) and low levels (0.5%) of serum, with each different clone at least 10 times, after 5 days of NGF stimulation. Since cells induced to express both wildtype and mutant Trks did not aggregate under low serum conditions, as compared to cultures grown in high amounts of serum, this simplified our quantification. Thus, neurite outgrowth assays were consistently performed under low serum conditions, following induction with both low and high concentrations of Dox. The fact that the mutant Trks could not support NGF-independent neuritogenesis of SY5Y cells is not surprising, given that the AspGlu and GluAsp mutants do not support NGF-independent autophosphorylation (see Figure 1a and b). As shown in Figure 2 , cells induced to express wild-type TrkA (clones 19, 20) , with minimal (0.2 mg/ml) or maximal (2 mg/ml) Dox, support NGF-dependent somatic hypertrophy as well as neurite enhanced neuritogenic responses (see Figure 3a) . The increase in neurite outgrowth as a result of lower levels of receptor expression, relative to the responses when higher levels of TrkA are expressed, is statistically significant with a P-value of o0.05 for Trk19. The possibility of a Dox-induced toxic effect accounting for changes in the neuritogenic responses found in Trk19 cells, when grown in low serum, is unlikely, since not all clones appear to respond to changes in Dox concentration in a similar manner. Thus, it appears that the neuritogenic response in cells expressing GluAsp cannot be modulated by varying levels of receptor and that the maximal response for GluAsp is approximately 60% of wild-type TrkA. Since the two AspGlu clones (A6 and A8) showed a significant difference in NGF-induced neurite outgrowth, we examined a third clone, A3. As shown in Figure 3b , S13a3 cells express levels of receptor comparable to Trk20, S13a6 and S13a8; yet its NGF-dependent neurite outgrowth is intermediate to the A6 and A8 lines. These observations collectively suggest that the S13a mutant is less able to support NGF-dependent neurite outgrowth, and that the differences between the lines likely reflect clonal variance. Lastly, comparison of the neurite outgrowth between the Trk clones (19, 20) with either 13a6/13a8 or 13b2/ 13b24, at low levels of Dox stimulation, revealed a decrease in neuritogenesis that is statistically significant with P-values of Po0.05.
To assess if the neuritogenic responses of cells expressing both wild-type TrkA and mutant Trks are accompanied by a corresponding decrease in the mitotic index, stable lines were grown for 5 days in the presence of either Dox (max: 2.0 mg/ml; min: 0.2 mg/ml) or Dox plus NGF (100 ng/ml), and assayed for changes in BrdU incorporation during the S phase. As shown in Figure 4a , both wild-type TrkA-expressing cells (Trk19 min; Trk20 max) and cells expressing GluAsp mutant Trk (13b2 and 13b24) show an NGF-dependent decrease in BrdU incorporation of approximately 26% for Trk19 (min, Po0.02), 36% for Trk20 (Po0.001), 34% for 13b2 (Po0.03) and 42% for 13b24 (Po0.02). The NGFdependent decrease in BrdU incorporation in cells overexpressing the AspGlu mutant did not show strong statistical significance corresponding to an approximate 17% decrease for 13a6 (P ¼ 0.3) and 13% for 13a8 (Figure 4a ). Re-examination of the third S13a clone, A3, relative to A6 and A8 indicates that the NGF-induced decrease in BrdU incorporation is comparable to clone A6 (Figure 4b ). In addition, an increase in wild-type TrkA expression in clone 19 (maximal Dox, 2 mg/ml; Figure 3a ) does not generate a corresponding decrease in BrdU incorporation (Figure 3b ), similar to the results of the neuritogenesis assay (Trk19, max Dox., Figure 3a ).
Activation of Akt
As discussed above, a well-known NGF-dependent mechanism by which TrkA stimulates cell survival involves the activation of PI-3 kinase, which in turn leads to the recruitment of the pleckstrin homology (PH) domain of the serine/threonine kinase, Akt, to the inner surface of the plasma membrane. Once localized to the membrane, Akt becomes activated by undergoing phosphorylation at two critical sites, Thr 308 and Ser 473 (Alessi et al., 1996) . (Figure 5b ). The levels of Doxinduced TrkA expression in each lysate are shown in Figure 5c . Similar results were found in three independent experiments.
NGF-dependent tyrosine phosphorylation of Shc
As discussed above, NGF stimulation of TrkA induces the tyrosine phosphorylation of the adapter protein Shc. Given that cells expressing wild type and/or mutant Trks cannot support NGF-independent autophosphorylation, only NGF-dependent tyrosine phosphorylation was assayed by immunoprecipitation and Western blotting. As shown in Figure 6a , all mutant Trks induce Shc tyrosine phosphorylation to levels comparable to NGF-activated cells expressing wild-type TrkA (Trk19, Trk20). Coimmunoprecipitation of tyrosine phosphorylated TrkA was detected in all immunoprecipitates (Figure 6a ). The levels of Dox-induced TrkA expression are shown in Figure 6b . Similar results were found in three independent experiments.
NGF-dependent tyrosine phosphorylation of PLCg-1
To determine if NGF stimulation leads to the tyrosine phosphorylation of PLCg-1 in SY5Y cells induced to express mutant Trks, cell lysates were analysed by immunoprecipitation and Western blotting. As shown in Figure 7a , all mutant Trks induce PLCg-1 tyrosine phosphorylation to levels comparable to NGF-activated cells expressing wild-type TrkA. Reprobing the blot with anti-PLCg-1 antibodies confirms that comparable amounts of proteins were loaded in each lane (Figure 7b ). Coimmunoprecipitation of tyrosine-phosphorylated TrkA was detected in all immunoprecipitates. The levels of Dox-induced TrkA expression are shown in Figure 7c . Similar results were found in three independent experiments. 
NGF-dependent tyrosine phosphorylation of MAP kinase/erks
As discussed above, NGF stimulation of TrkA activates the Ras signalling pathway, resulting in MAP kinase/erk activation. Since prolonged MAP kinase activation is an important correlate of differentiation, we determined if cells induced to express the mutant Trks would support MAP kinase/erk phosphorylation/activation. Tyrosine phosphorylation of erk1/2 was assayed in cells induced with Dox (2.0 or 0.2 mg/ml, 24 h) and stimulated with NGF (100 ng/ml, 10 min) by Western blotting with antibodies directed against the active form of MAP kinase. As shown in Figure 8a , all mutants support NGF-dependent activation of MAP kinase following 10 min NGF stimulation. To determine if the kinetics of MAP kinase activation are comparable between cells expressing wild-type TrkA and/or AspGlu and GluAsp, we examined the NGF-dependent pattern of MAP kinase activation in cells induced to express the Trk receptors. As shown in Figure 8b and d, with the exception of 13b2, the activation of MAP kinase in cells expressing wild-type TrkA and mutant Trks does not change over a period of 7 h. Reprobing the membranes with anti-erk antibodies shows that comparable amounts of protein were loaded (see Figure 8c and e). The levels of Dox-induced TrkA expression are shown in Figure 8f . Similar results were found in three independent experiments.
NGF-dependent tyrosine phosphorylation of FRS2
As discussed in the introduction, NGF-dependent activation of TrkA leads to the tyrosine phosphorylation of FRS2 both in PC12 cells and in the human NB cell line, SY5Y. Thus, we assayed NGF-dependent tyrosine phosphorylation of FRS2 in cells induced to express AspGlu and GluAsp. To examine FRS2 tyrosine phosphorylation, SY5Y cells were induced with Dox (2 mg/ml, 24 h) prior to NGF stimulation (100 ng/ml, 10 min) and lysis. As shown in Figure 9a , all mutant Trks support tyrosine phosphorylation of FRS2. Reprobing the blot with anti-FRS2 antibodies confirms that comparable amounts of proteins were loaded in each lane (Figure 9a ). Interestingly, slightly decreased levels of FRS2 tyrosine phosphorylation were detected in cells expressing AspGlu (13a6, 13a8), which was not attributable to lower levels of receptor expression (Figure 9b) . Similar results were observed in three independent experiments.
NGF-dependent tyrosine phosphorylation of SH2B
Finally, it has previously been shown that NGF stimulation of SY5Y cells overexpressing wild-type TrkA leads to the tyrosine phosphorylation of SH2B (Eggert et al., 2000) . While the tyrosine phosphorylation of SH2B cells is not readily detected in PC12 cells, it can be detected in SY5Y cells, suggesting that different pathways are activated in PC12 cells and SY5Y cells and that, possibly, different mechanisms may be involved in the NGF response in these two cell lines. Thus, we were interested if there were any differences between wildtype TrkA and the mutant Trks, in their ability to stimulate tyrosine phosphorylation of SH2B in SY5Y cells. As shown in Figure 10a (upper panel), AspGlu and GluAsp mutant Trks support NGF-dependent tyrosine phosphorylation of SH2B to levels comparable to NGFactivated wild-type TrkA. Reprobing the blot with anti-SH2B antibodies confirms that comparable amounts of proteins were loaded in each lane (Figure 10a , lower panel). The levels of Dox-induced TrkA expression are shown in Figure 10b . Similar results were obtained in three independent experiments.
Discussion
NBs expressing wild-type TrkA respond to NGF by undergoing differentiation in vitro. In this study, we were interested if two mutants in the activation loop tyrosines in TrkA (AspGlu and GluAsp), which have previously been shown to induce NGF-independent kinase activation, cell survival and neuritogenesis in stably transfected nnr5 cells , could also support NGF-dependent and/or NGFindependent differentiation in the human NB cell line, SY5Y. We demonstrate that, unlike our previous observations in nnr5 cells, the AspGlu and GluAsp mutant Trks cannot support NGF-independent autophosphorylation and/or NGF-independent differentiation of stably transfected SY5Y cells. Moreover, NGFdependent neuritogenesis by the AspGlu and/or GluAsp Trks in SY5Y cells is somewhat compromised in contrast to findings in nnr5 cells, where they supported NGF-dependent neuritogenesis comparable to that of NGF-activated wild-type TrkA. In addition, we find that increased TrkA expression does not enhance the biological responses, but may, in fact, inhibit neuritogenesis and cell cycle arrest.
Autophosphorylation and biological responsiveness
Previous examination of TrkA signalling in SY5Y cells has indicated that NGF-dependent differentiation of SY5Y cells depends on TrkA kinase activity (Eggert et al., 2000) . While AspGlu and GluAsp mutant Trks support NGF-independent autophosphorylation in stably transfected nnr5 cells, it was not apparent as to why these same mutant Trks, when transfected into SY5Y cells, could not undergo autophosphorylation in the absence of NGF treatment. However, correlation between the level of receptor expression in SY5Y cells and that in nnr5 cells indicates that the lack of autophosphorylation by AspGlu and GluAsp may be primarily due to lower levels of receptor expression. Consistent with this model, adenoviral infection and expression of AspGlu and GluAsp, to levels approximately 250 times those found on PC12 cells, supports NGF-independent autophosphorylation (Figure 1) .
Moreover, while AspGlu and GluAsp support NGFindependent and also NGF-dependent neuritogenesis of nnr5 cells that are comparable to that of wild-type TrkA , the mutant Trks appear to be compromised in their ability to do the same in SY5Y cells. Specifically, we show that AspGlu and GluAsp support NGF-dependent neuritogenesis of SY5Y cells that are approximately 30-60% of wild-type TrkA. Eggert et al. (2000) have also shown partial reconstitution of neuritogenesis (50-70%) in cells, following retroviral infection, stably expressing Trks for which F for PLCg-1). Given that these sites are outside the catalytic domain, these observations suggest that the activation loop tyrosines on TrkA, themselves, contribute to the responsiveness of SY5Y cells, but that none of the pTyr sites are singularly essential to neuritogenesis in SY5Y cells. Moreover, while SH2B is thought to directly bind the activation loop tyrosines and its overexpression can reconstitute the ability of a Shc/PLCg-1 minus receptor to support differentiation, our observation that both AspGlu and GluAsp mutants retain NGF-dependent SH2B phosphorylation indicates that there is at least one additional indirect route, probably mediated via its Grb2-binding properties (Qian et al., 1998) , by which Trk can activate SH2B. It is not clear, however, why AspGlu (approximately 30%) appears to be more defective in supporting neuritogenesis than GluAsp (approximately 60%), especially since there were no differences between the two mutant Trks in nnr5 cells . It can be argued, however, that there may be an apparent preference for glutamic acid at Tyr 683 to generate a more stable form of the receptor in SY5Y cells, which in turn facilitates restoration of neuritogenesis to a greater extent than that of AspGlu. Consistent with this model, the AspGlu mutant Trk shows slightly lower levels of FRS2 and SH2B tyrosine phosphorylation, and does not induce cell cycle arrest as effectively as the GluAsp mutant.
Independently, differences in the neuritogenic responses between wild-type TrkA and the AspGlu and GluAsp mutant Trks may be attributed to differences in levels of p75 NTR interaction. Accordingly, it has been shown that NGF binding to TrkA is positively modulated in the presence of p75 NTR and that higher levels of p75 NTR are found in nnr5 cells than in SY5Y cells. Therefore, it is possible that higher expression of p75 NTR in stably transfected nnr5 cells positively modulates AspGlu and GluAsp to induce NGFindependent and NGF-dependent neuritogenesis. Conversely, the lack of p75 NTR expression (or highly reduced levels) in SY5Y cells may account for the decreased responsiveness in SY5Y cells.
Recently, the effects of internalization on receptor signalling and biological responses have been investigated. It is now known that Trks remain activated following internalization into vesicles (Ehlers et al., 1995; Grimes et al., 1996; Bhattacharyya et al., 1997; Grimes et al., 1997; Howe et al., 2001; Wu et al., 2001) . It is believed that Trks are internalized into clathrincoated vesicles, since the endocytic protein, dynamin, has been shown to play a role in TrkA internalization (Zhang et al., 2000) . Moreover, it has been demonstrated that neuronal differentiation of PC12 cells is promoted by catalytically active TrkA receptors, localized to vesicles inside the cell (Zhang et al., 2000) . In contrast, cell survival responses are initiated by activated receptors at the cell surface (Zhang et al., 2000) . In view of these findings, and also observations that show that acidic amino-acid substitution mutant Trks do not restore NGF-independent neuritogenesis completely and can support NGF-independent cell survival in stably transfected nnr5 cells , the intracellular trafficking of these mutant Trks may be compromised and the majority of cell signalling may come from receptors at the cell surface. Potential changes in the intracellular trafficking of the mutant Trks could provide a rationale for their inability to fully restore NGF-dependent neuritogenesis in SY5Y cells and is the subject of ongoing investigations.
Cell signalling
Much is known about cell signalling induced by NGFactivated TrkA. Most of the evidence comes from studies in PC12 cells, in which it has been demonstrated that at least four pathways are essential for NGFdependent differentiation. Specifically, we know that prolonged activation of MAP kinase (Marshall, 1995) , tyrosine phosphorylation of the suc1-neurotrophic factor target protein, SNT (Rabin et al., 1993) and/or the adapter protein FRS2 (Kouhara et al., 1997; Meakin et al., 1999) , the activation of the SH2 domain-containing tyrosine phosphatase Syp2 (Wright et al., 1997) and activation of the p38 kinase (Morooka and Nishida, 1998) , are all hallmarks of NGF-dependent differentiation of PC12 cells. We show in this study that cells expressing AspGlu and GluAsp support transient NGFdependent tyrosine phosphorylation of PLCg-1 and adapter proteins such as Shc, SH2B and FRS2, as well as prolonged MAP kinase activation, but are not able to fully restore NGF-dependent neuritogenesis. It has already been shown that tyrosine phosphorylation of neither Y 499 nor Y 794 (in rat TrkA) is essential for full NGF-dependent differentiation of SY5Y cells (Eggert et al., 2000) . Thus, in order to correlate neuritogenesis of SY5Y cells to NGF-induced signalling, it will be important to examine the kinetics of activation of individual pathways.
Finally, correlation between the transient activation of cell signalling in SY5Y cells and compromised neuritogenic responses of cells expressing GluAsp suggests that the activation of neither SH2B, PLCg-1 and Shc nor FRS2 is sufficient for full NGF-induced differentiation of SY5Y cells. However, tyrosine phosphorylation of FRS2 and SH2B appears to be of greater importance for the differentiation of SY5Y cells, since it is consistently lower in cells overexpressing AspGlu mutant Trk, in comparison to either cells expressing wild-type and/or GluAsp TrkA receptors. Given that none of the mutant Trks restored neuritogenic responses to levels comparable to wild-type TrkA suggests also that other pathways, yet undescribed, contribute to the differentiation of NBs, and that it is likely that there is no single pathway that is dominant and absolutely essential for NGF-mediated differentiation of NBs. Alternatively, it is possible that changes in the stoichiometric activation of intracellular targets are important during differentiation of SY5Y cells.
Additional studies will be required to dissect the signalling events leading to NGF-induced and TrkAmediated differentiation of SY5Y cells. For instance, it has been shown that prolonged activation of MAP kinase and neuritogenic responses of PC12 cells is dependent on the activation of the Ras-related small G protein Rap 1 (York et al., 1998) . Also, the localization of the activated forms of another small G protein, Rac 1, into the actin-rich protrusions in PC12 cells appears to initiate the process of neurite formation of PC12 cells, which is also dependent on PI-3 kinase activation (Yasui et al., 2001) . Collectively, these observations suggest that it is reasonable to evaluate TrkA-activated signalling pathways that are required for NGF-induced differentiation which are downstream from TrkA, and the activation of which may not be the result of direct association with TrkA.
Materials and methods
Antibodies, NGF and reagents
Rabbit antibodies to Trk (C-terminal 14 a.a.) were generated using standard techniques. Hybridoma 9E10 cells (anti-c-Myc) (Evan et al., 1985) were grown as ascite tumors in 4-6-weekold female Balb/c mice and purified by protein G affinity chromatography using standard techniques. The horseradish peroxidase (HRP)-coupled anti-pTyr antibody, RC20, was from Transduction Labs. The rabbit polyclonal antibody to Shc was from J McGlade (Hospital for Sick Children, Toronto). The mouse monoclonal antibody to PLCg-1 was from UBI. Rabbit antibody to MAPK was from S Pelech (Kinetek Biotec. Corp., Vancouver). Rabbit polyclonal antibodies to active MAPK were from Promega and antibodies to active AKT (pSer 473 and pThr
308
) were from New England Biolabs. The rabbit polyclonal antibody to FRS2 was from Santa Cruz. The rabbit polyclonal antibody to SH2B was from D Ginty (The Johns Hopkins University School of Medicine, Baltimore, MD, USA). HRP-goat anti-rabbit and HRP-goat anti-mouse secondary antibodies were from The Jackson Laboratory. Fluorescein isothiocyanate (FITC)-goat antimouse IgG (1 mg/ml) was from Calbiochem. b-NGF was from Harlan Bioproducts for Science. Hygromycin was from Roche Diagnostics Corp. Doxycyline was from Sigma.
Plasmids
HA-tagged wild-type TrkA, AspGlu and GluAsp mutants were subcloned into the Tet-inducible vector, pBig3i (Strathdee et al., 1999) using standard procedures. The pBig3i vector is an autoregulated bidirectional expression vector, in which a weaker minimal TK (herpes simplex virus thymidine kinase) promoter is used to direct expression of the reverse tetracycline trans-activator (rtTA) and the stronger tetracycline-responsive human CMV (cytomegalovirus immediate early promoter) element is used to direct expression of a gene of interest.
Cell culture
HEK 293 (Graham et al., 1977 ; ATCC) cells were grown in DMEM containing 5% supplemented calf serum and 5% fetal bovine serum. The human NB cell line, SY5Y (Sonnenfeld and Ishii, 1982 ; gift of HU Saragovi, McGill University, Montreal), was grown in DMEM containing 5% supplemented calf serum and 5% fetal bovine serum. Recombinant adenoviruses were generated within 5-7 days and the amplification of infectious particles was performed by repeated freeze-thawvortex cycles of collected cells. Subsequent to this, cell debris was pelleted by centrifugation (1500 g, 2 min) and the supernatant was used to reinfect HEK 293 cells. Given that recombinant adenoviruses derived from the pAdTrack shuttle vector carry the GFP marker, both infection efficiencies and titers were determined by scoring the number of green cells following 24 h expression.
Neurite response assay and 5-bromo-2-deoxyuridine (BrdU) assay SY5Y clones expressing wild-type TrkA (clones: Trk19, Trk20), AspGlu (clones: 13a6, 13a8) and GluAsp (clones: 13b2, 13b24), as well as untransfected SY5Y cells, were plated on poly-d-lysine-coated plates (approximately 1 Â 10 4 cells per dish). Cells were grown for 10 days in DMEM containing 0.5% supplemented calf serum, NGF (100 ng/ml) and varying amounts of Dox (0.2 and 2.0 mg/ml). Dox-induced neurite outgrowth was scored microscopically at 5 days by counting the number of cells with neurites (at least 2 cell body length) in 10 independent fields (120-200 cells). The results are presented as a percentage of cells with neurites in relation to the number of cells stained positive for Trk expression when analysed by FACS. Three independent experiments were performed.
Changes in proliferation were assayed in stable clones of SY5Y cells grown on poly d-lysine-coated 24-well clusters. Both Dox and NGF were added every day. On day 5, cells were assayed for changes in proliferation by measuring the incorporation of the thymidine analogue, BrdU, as described in the manufacturer's protocol (5-bromo-2-deoxyuridine labelling and detection kit I; Roche Diagnostics Corp.). The percentages of BrdU-positive cells were scored in three independent experiments from 4 to 5 independent frames. Approximately 80-100 cells were counted per independent frame in each experiment.
Determination of Trk receptor expression and Trk receptor autophosphorylation
Cells were stimulated with Dox (2.0 or 0.2 mg/ml, 24 h) and lysed in NP-40 lysis buffer (20 mm Tris-Cl, pH 8.0, 137 mm NaCl, 0.5 mm EDTA, 10% glycerol and 1% NP-40) containing 1 mm PMSF, 2 mg/ml leupeptin, 10 mg/ml aprotinin and 1 mm sodium orthovanadate (Na 2 VO 4 ). To estimate the levels of Trk expression, equal amounts of protein (50-100 mg) were analysed by Western blotting with anti-HA (3F10; 1 : 2500) and HRP-conjugated goat anti-mouse (1 : 10 000) antibodies.
To determine the level of Trk receptor autophosphorylation, equal amounts of protein (500 mg) were immunoprecipitated with anti-Trk antibodies and Western blots were probed with anti-pTyr antibodies, RC20, and reprobed with anti-HA antibodies as described above. The chemiluminescence detection kit was from NEN Life Science Products. Densitometry was performed using the Imaging Densitometer, Model GS-700 (BioRad).
Shc, PLCg-1, SH2B, MAP kinase, Akt and FRS2 assays Cells were cultured with Dox (0.2 mg/ml) for 24 h and stimulated with NGF (100 ng/ml, 9-10 min) prior to lysis. For Akt assays, cells were cultured as above, with the exception that serum-free media was added for 1 h prior to NGF stimulation (100 ng/ml, 15 min). Cells were lysed in icecold NP-40 lysis buffer containing protease inhibitors and 1 mm sodium vanadate, as described above. Equal amounts of protein (750 mgÀ1 mg) were immunoprecipitated with rabbit anti-Shc (7.5 mg), mouse anti-PLCg-1 (0.5 mg), rabbit anti-SH2B (4 ml) or rabbit anti-FRS2 (0.8 mg) antibodies at 41C overnight. Blots were probed with RC20 as described above, stripped and reprobed with 2 mg/ml rabbit anti-Shc, 0.1 mg/ml mouse anti-PLCg-1, 0.4 ml/ml rabbit anti-SH2B and 0.8 mg/ml rabbit anti-FRS2 antibodies and counterstained with HRPcoupled secondary antibodies (1 : 10 000).
For MAP kinase and Akt assays, whole-cell lysates were analysed by Western blotting. Either 10 or 100 mg of whole-cell lysates were analysed by Western blotting with antiactive MAPK (1 : 10 000) or with antiactive Akt (pSer 473 , pThr 308 ; 1 : 10 000), and reprobed with rabbit anti-MAPK (1 : 10 000) and rabbit anti-Akt (1 : 10 000) antibodies, respectively (see above). The chemiluminescence detection kit was from NEN Life Science Products.
